Scientists have discovered a promising new strategy to fight pancreatic cancer using experimental compounds known as PCAIs. In laboratory studies, a leading PCAI compound blocked more than 90% of cancer cell migration, suggesting it could help prevent tumor spread. Instead of shutting down cancer-promoting signals, the treatment took an unusual approach by hyperactivating key cellular pathways, pushing cancer cells beyond their limits and triggering self-destruction. This innovative mechanism could offer a new way to target one of the most aggressive and treatment-resistant cancers. While the results are highly encouraging, further preclinical and clinical studies are needed to confirm the therapy’s safety and effectiveness.
Read more at ScienceDaily